Freshly Printed - allow 10 days lead
Stem Cells and COVID-19
A comprehensive reference for the diagnosis, treatment and prevention of COVID-19 using stem cells
Chandra P. Sharma (Edited by), Devendra K. Agrawal (Edited by), Finosh G. Thankam (Edited by)
9780323899727, Elsevier Science
Paperback, published 22 April 2022
248 pages, 60 illustrations (50 in full color)
23.5 x 19 x 1.7 cm, 0.52 kg
Stem Cells and COVID-19 presents up-to-date knowledge on the effect of hematopoietic and mesenchymal stem cells to combat SARS-CoV-2 infection in its diagnosis, treatment and prevention. In addition, the book critically discusses challenges, highlighting outstanding questions and future perspectives. Written by global experts in the field for both pre-clinical and clinical practitioners, this comprehensive book delves into how stem cells have a strong potential in developing better diagnostic, treatment and preventive strategies in SARS-CoV-2 infection. Both hematopoietic and mesenchymal stem cells are critical to better understand the response of immune system to coronavirus infection in both healthy and co-morbid conditions in the development of effective vaccines and immunotherapies.
1. Introduction
2. Characteristics and Immunobiology of COVID19
3. Molecular Mechanism and translation approaches
4. Inflammatory multisystem syndrome in COVID19: Insights on off-target organ system in susceptible and recovering population
5. Cytokine storm and stem cell activation in unveiling potential targets for diagnosis and therapy
6. Mesenchymal and hematopoietic stem cells: Novel avenues in combating COVID19
7. Immunomodulatory properties of mesenchymal and hematopoietic stem cells – potential therapeutic target for COVID-19
8. COVID19 and acute myocardial injury: Stem cell driven tissue remodeling in COVID19 infection
9. Stem cell born signals and tissue regeneration in COVID19 infection
10. Stem cell transplantation COVID19 management: Translational possibilities and future
11. Therapeutic scale stem cell-derived exosomes for COVID - 19: Models – Validation, Management & Strategies
12. Therapy: present & future clinical perspective
Subject Areas: Life sciences: general issues [PSA]